The 2023 European environmental tax revenue in the chemical and pharmaceutical manufacturing sector highlights varied trends across countries. France leads with $2.79 billion, despite a slight -3.05% decline. The UK and Italy follow, exhibiting minor contractions. Poland and Hungary showcase significant growth at 8.61% and 9.97% respectively, while Denmark and Finland face sharper declines at -8.43% and -11.41%. Emerging markets like Estonia and Malta demonstrate notable increases, reflecting targeted policy impacts.
Future trends to monitor:
- Potential stabilization in traditional markets like France and the UK as environmental regulations solidify.
- Growth acceleration in emerging markets due to the adoption of greener manufacturing practices.
- Increased pressure for tax reforms in underperforming economies to incentivize sustainable manufacturing.
Top countries in Environmentally Related Tax Revenue from All Environmental Taxes in Manufacturing of Chemicals, Basic Pharmaceuticals and Preparations by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 2,790 | 2023 | -0.62% | -3.05% | View data |
| 2 | 2 United Kingdom | 493.71 | 2023 | -1.84% | -2.39% | View data |
| 3 | 3 Italy | 471.83 | 2023 | +0.46% | -0.28% | View data |
| 4 | 4 Poland | 387.54 | 2023 | +4.22% | +8.61% | View data |
| 5 | 5 Netherlands | 305.75 | 2023 | +1.18% | +1.44% | View data |
| 6 | 6 Belgium | 216.97 | 2023 | -5.15% | -3.25% | View data |
| 7 | 7 Czech Republic | 174.19 | 2023 | -5.25% | -5.83% | View data |
| 8 | 8 Serbia | 160.13 | 2023 | +2.7% | -0.2% | View data |
| 9 | 9 Austria | 104.62 | 2023 | +3.36% | +3.15% | View data |
| 10 | 10 Slovenia | 104.48 | 2023 | -2.44% | -3.67% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
